OT ULTRAMINI METER
Report
- Report Number
- 3008382007-2013-16387
- Event Type
- Injury
- Date Received
- June 11, 2013
- Report Date
- May 23, 2013
- Manufacturer
- LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
- Product Code
- NBW
- PMA / PMN Number
- K061118
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MT, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.
ON (B)(6) 2013 THE LAY USER/ PATIENT CONTACTED LIFESCAN (LFS) ALLEGING HER ONETOUCH ULTRAMINI METER HAD BLACK MARKS ON THE DISPLAY. THE COMPLAINT WAS CLASSIFIED BASED ON THE CUSTOMER CARE ADVOCATE (CCA) DOCUMENTATION. THE PATIENT WAS UNABLE TO RECALL WHEN THE ALLEGED ISSUE FIRST STARTED. THE PATIENT REPORTED USING SELF ADJUSTING INSULIN TO MANAGE HER DIABETES. THE PATIENT REPORTED ON AN UNKNOWN DATE AND TIME SHE EXERCISED IN RESPONSE TO THE ALLEGED ISSUE. THE PATIENT REPORTED DEVELOPING SYMPTOMS OF ¿HIGH BLOOD GLUCOSE¿ 24 HOURS AFTER THE ALLEGED ISSUE OCCURRED. THE PATIENT REPORTED ON AN UNKNOWN DATE AND TIME SHE WAS TREATED IN THE EMERGENCY ROOM OR HOSPITAL FOR A BLOOD GLUCOSE OF ¿ 713 MG/DL¿ WITH INSULIN. AT THE TIME OF TROUBLESHOOTING, THE CCA WAS ABLE TO DETERMINE THIS WAS NOT THE FIRST TIME THE METER HAD BEEN USED, AND THERE WAS NO MISUSE OF THE PRODUCT. REPLACEMENT PRODUCTS WERE SENT. THIS COMPLAINT IS BEING REPORTED AS AN ADVERSE EVENT SINCE THE PATIENT CLAIMS, DUE TO THE ALLEGED ISSUE, WAS UNABLE TO TEST AND THEREFORE DEVELOPED EXTREMELY HIGH BLOOD GLUCOSE AND REQUIRED TREATMENT FROM A HEALTH CARE PROFESSIONAL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 262687 | OT ULTRAMINI METER | GLUCOSE MONITORING SYS/KIT | NBW | LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL | 3357278 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 31 YR | Hospitalization| L| R |